x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr. Chapa’s OBGYN Clinical Pearls

Dr. Chapa’s Clinical Pearls

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

science

All Episodes

00:16:12

IV vs Oral Iron Therapy in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/04/04

Iron deficiency anemia during pregnancy has been linked to several obstetrical adverse events including preterm birth, low birth weight, Cesarian Section, and of course the need for blood transfusion. Babies born to iron deficient mothers are also at risk of being iron deficient themselves- a condition which has been linked to poor psychosocial development. In this session, we will review the data favoring IV iron therapy over oral iron therapy during pregnancy and the postpartum period, especially

en

00:13:13

Prolactinomas in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/04/01

Prolactinomas are categorized as micro- or macroadenomas based on their size. These tumors are considered the most frequently diagnosed functioning, anterior pituitary tumor type. Most women with microprolactinomas will have no adverse effects during pregnancy; however, macroadenomas are at risk of tumor growth. In this session we will review the endocrine society’s management plan of prolactinomas during pregnancy.

en

00:10:30

Pavovirus B19 in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/31

Parvovirus B 19 is a single-stranded DNA virus that causes the childhood exanthem known as fifth disease. The risk of maternal Parvo B19 infection varies with the level of exposure to the infected individual. Parvo B19 may cause asymptomatic fetal infection or may result in fetal loss, hydrops fetalis, or stillbirth. Currently, the ACOG does not recommend universal screening of Parvo B19 immunity. In this session, we will review the ACOG data on maternal and fetal Parvo B19 infection.

en

00:10:44

Toxoplasmosis in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/29

In the United States, 1 out of 1,000-8,000 babies are born with toxoplasmosis. Vertical transmission increases per trimester but severity of fetal disease increases the earlier in pregnancy that transmission occurs. In this episode, we will review the ACOG data on maternal and fetal infection with T. gondii.

en

00:13:52

CMV in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/29

CMV is the most common congenital infection, occurring in 0.2 to 2.2% of all neonates. Vertical transmission of this herpesvirus is possible throughout all pregnancy with increasing rates of transmission per trimester (3 > 1). In the session, we will review the ACOG data on maternal and fetal CMV infection.

en

00:08:53

Do OCPS help ovarian cysts resolve?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/28

Historically, oral contraceptive pills were prescribed in attempt to help quicken resolution of ovarian cysts. Is this practice evidence-based? In this session we will review the Cochrane Database regarding this topic as well as the mechanism of action of how certain contraceptives (etonogestrel/levonorgestrel) pre-dispose to the “unruptured ovarian follicle“.

en

00:13:40

Universal Low-Dose ASA Use In Pregnancy?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/25

In 2018, The ACOG expanded the possibility of low-dose aspirin use in pregnancy for preeclampsia prevention. Women deemed at moderate risk (1 or more risk factor), or high-risk (only 1 high risk factor needed) were included in low-dose ASA prophylaxis. Now, a call is being made to consider “universal adoption“ of this low-cost, low risk intervention. This is a summary of this soon to be published (green journal) current commentary, “A nudge towards universal aspirin for preeclampsia

en

00:06:56

The PROLONG trial: Does 17-OH really prevent preterm...

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/20

Recently, the PROLONG Trial, investigating 17-OHP’s role in preventing recurrent preterm birth, called into question the effectiveness of this treatment regimen. However, most of the study patients in the manufacturer’s initiated study were outside of the United States and were significantly different than the original MFMU study participants. In this session, we will review both of these studies and put the results into proper perspective.

en

00:14:45

VTE and Gyn Surgery

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/16

In 1858, Virchow reported on the triad of hypercoagulability, venous stasis, and vessel wall injury as the factors pertinent to venous thromboembolism. In this session, we will review the ACOG practice bulletin as well as the executive summary from the American College of Chest Physicians regarding VTE in gynecological surgery.

en

00:09:19

Do BC Pills have to be stopped before GYN surgery?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/10

Postop DVT and PE are potentially devastating to a postop patient. What does the ACOG and the American College of Chest Physicians say about stopping hormone replacement therapy or oral contraceptive pills before surgery? Let’s take a look at the data.

en

00:06:59

One abnormal value on 3 Hr GTT: Implications?

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/03/07

In the United States, GDM is diagnosed by a 3 hour GTT when 2 or more values are above a designated cut off. But what happens when only one value is elevated? In this session, we will review the data regarding this clinical dilemma. We will also review if there is a clinical difference if the 1 elevated value is the fasting blood sugar or 1 of the 3 post glucose challenge. Data taken from SMFM briefings.

en

00:09:01

ACOG: Umbilical Cord Blood Banking

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/26

Umbilical cord blood banking still carries significant misperceptions regarding its potential use. Did you know, that umbilical cord blood is not meant to be used as in an AUTOLOGOUS transplant because stored cord blood contains the same genetic variant or pre-malignant condition that led to the condition being treated in the donor! In other words, a child who develops a genetic condition cannot be treated with his own donated umbilical cord blood! In this session, we will summarize the ACOG

en

00:11:27

NS or LR: The IV Fluid Battle May Have Ended.

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/23

IV fluids?! Does it really make a difference if the patient receives normal saline (NS) or Lactated Ringers (LR)? Well, for short bouts of rehydration (1L to 2 L), probably not. However, data now confirms that prolonged IV therapy with NS results in poorer outcomes compared to LR! In this episode, we will review the basic science of a “balanced“ IV fluid and review the data which has now placed LR at the forefront of IV fluid hydration.

en

00:01:50

FOAMed!!

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/20

FOAMed!!! A shout out to “free open access medical education”. Thanks for the information, Scott C.-one of our clinical medical students!

en

00:13:21

Vanishing Twin Syndrome

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/20

Incredibly, Although the frequency of multiple gestation is 3 to 5% at 8 weeks, vanishing twin syndrome occurs in 20-30% of all multifetal gesstations! This is not a rare occurrence. Maternal and fetal morbidity- and possibly mortality- is linked to the timing of the single fetal loss. Risks increase when a single fetus is lost in the second or third trimester. In this session, we will review the ACOG and SMFM Data regarding the vanishing twin syndrome.

en

00:12:10

HIV PrEP

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/14

According to the CDC, 1 in 8 of the 1.2 million people living with HIV in the United States are unaware of their HIV status and only half of those known to be infected are receiving effective anti-retroviral therapy. The combination pill tenofovir/emtricitabine has been FDA approved for pre-exposure prophylaxis (PrEP). In this podcast will review the current state of PrEP therapy. (Reference: HIV pre-exposure prophylaxis, a review: JAMA, 2018.)

en

00:08:35

Screening for Perinatal Depression

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/11

Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period. According to the ACOG, 1 in 7 women are affected by perinatal depression! In this session we will review the ACOG committee opinion on screening for perinatal depression from the winter of 2018 (committee opinion 132).

en

00:15:30

Polyhydramnios

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/08

Polyhydramnios is an abnormal increase in amniotic fluid volume typically diagnosed in the second or third trimester. Either the single deepest vertical pocket or AFI can be used for diagnosis. The two most common pathological causes are maternal diabetes and fetal anomalies. In this session, we will summarize the SMFM consult series #46 (2018) on the evaluation and management of polyhydramnios.

en

00:14:52

DKA in Pregnancy

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/06

Diabetic ketoacidosis in pregnancy is an obstetric and medical emergency and therefore requires prompt and aggressive treatment in a specialized care unit. Prompt and aggressive IV fluid management, IV insulin administration, and attention to key electrolytes are foundational to DKA management. In this podcast, we will review the SMFM protocol for DKA management in pregnancy.

en

00:06:37

Glycemic Effects After Steroids for FLM

Dr. Chapa’s OBGYN Clinical Pearls ·

2019/02/04

Corticosteroid therapy for fetal lung maturity was first endorsed back in 1994. But what do we know about its affect on glycemic levels? Pregnant women with gestational diabetes, and of course pre-existing diabetes, are at higher risk of DKA at “lower” hyperglycemic levels compared to non-pregnant individuals. In this session, we will review the data on the effect of antenatal corticosteroids on the mothers’ glycemic levels.

en

1,105 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter